Trial Profile
Immunogenicity and safety study of Rabies G protein Vaccine administered as a simulated post-exposure immunization in healthy volunteers
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 25 Jan 2019
Price :
$35
*
At a glance
- Drugs Rabies G protein vaccine CPL Biologicals (Primary) ; Rabies vaccine
- Indications Rabies
- Focus Pharmacodynamics; Registrational
- Sponsors Cadila Pharmaceuticals
- 22 May 2017 Status changed from not yet recruiting to active, no longer recruiting.
- 01 Sep 2016 New trial record